Important notice regarding changes to the law affecting Continuing Education requirements for Controlled Substance Registrants and Re-registrants:
Effective July 1st, 2019, pursuant to Senate Enrolled Act 225-2018, a practitioner who is licensed by a board and applies for registration or re-registration to distribute or dispense a controlled substance must have completed two (2) hours of continuing education during the previous two (2) years addressing the topic of opioid prescribing and opioid abuse.
For more information and a copy of Senate Enrolled Act 225-2018, please visit the Indiana General Assembly website at iga.in.gov.
From the Indiana State Medical Association: ISMA is in a unique position to take the lead in educating the state’s physicians about opioid prescribing and addiction. As the largest physician organization in Indiana advocating for the well-being of physicians and their patients, and as the Indiana recognized accreditor of continuing medical education (CME) for 31 institutions, including hospitals and medical specialty societies, ISMA is committed to implementing solutions to combat Indiana's opioid crisis.
7-part series, case-based content that demonstrates and instructs participants on how the 12 recommendations of the CDC Guideline for Prescribing Opioids for Chronic Pain are applied in a primary care setting.
From the National Institute on Drug Abuse. Developed by NIDA and Medscape Education, with funding from the White House Office of National Drug Control Policy, these CME courses provide practical guidance for physicians and other clinicians in screening pain patients for substance use disorder risk factors before prescribing, and in identifying when patients are abusing their medications. The courses use videos that model effective communication about sensitive issues, without losing sight of addressing the pain.